Advances in Hematological Malignancies
Recent decades have witnessed remarkable advancements in the field of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and gene editing are altering the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative techniques, offering potential for more curative trea